Letter Agreement for Stock Option Grant and Acceptance



 Exhibit 10.27 
 May 12, 2006 
 Adam Logal 
 3194 Quantum Lakes
Drive 
 Boynton Beach, FL 33426 
 Re: Letter Agreement for Stock
Option Grant and Acceptance Between Nabi Biopharmaceuticals and Adam Logal 
 Dear Mr. Logal: 
 I am pleased to report that for good and valuable consideration, receipt of which is hereby acknowledged, Nabi Biopharmaceuticals, a Delaware corporation
(the “Company”), does hereby grant to you (the “Optionee”) an option to purchase Twenty Thousand (20,000) shares of Common Stock of the Company (the “Option”), pursuant to the terms of the Company’s
2000 Equity Incentive Plan (the “Plan”) and the terms and conditions set forth below. A copy of the Plan is attached hereto and is incorporated herein in it entirety by reference. 
 The Optionee hereby accepts the Option subject to all of the provisions of the Plan, and upon the following additional terms and conditions: 

1. The price at which the shares of Common Stock may be purchased pursuant to the Option is $ 6.30 per share, subject to adjustment as
provided in the Plan. 
 2. (a) The Option shall expire at the close of business on the seventh anniversary of the date hereof (the
“Expiration Date”). Subject to the following provisions of this Section 2 and to the provisions of the Plan, the Option shall be exercisable before said Expiration Date as follows: (i) if the Optionee is employed by the Company
on the first anniversary of the date hereof, to the extent of 25% of the number of shares covered hereby; (ii) if the Optionee is employed by the Company on the second anniversary of the date hereof, to the extent of 50% of the number of shares
covered hereby, less the number of shares covered hereby, less the number of shares as to which the Option has been exercised previously; (iii) if the Optionee is employed by the Company on the third anniversary of the date hereof, to the
extent of 75% of the number of shares covered hereby, less the number of shares as to which the Option has been exercised previously; and (iv) if the Optionee is employed by the Company on the fourth anniversary of the date hereof, to the
extent of the full number of shares covered hereby, less the number of shares as to which the Option has been exercised previously. The Option may not be exercised at all during the first year after the date hereof (except to the extent provided in
the Plan) or after the Expiration Date. 
 (b) If the Optionee’s employment is terminated by the Company for “cause”, the
Option shall terminate automatically and without notice to the Optionee on the date the Optionee’s employment is terminated. For purposes hereof, “cause” shall mean (i) illegal or disreputable conduct which impairs the
reputation, good will or business of the Company or involves the misappropriation of funds or other property of the Company, (ii) willful misconduct by the Optionee or willful failure to perform his or her responsibilities in the best interests
of the Company (including, without limitation, breach by the Optionee of any provision of any employment, advisory, consulting, nondisclosure, non-competition or other agreement between the Optionee and the Company or any subsidiary of the Company,
(iii) refusal or failure to carry out any employment duties reasonably assigned to the Optionee other than by reason of death or employment duties for the Company, or (iv) demonstrated negligence or gross inefficiency in the execution of
the Optionee’s employment duties for the Company. Any resignation in anticipation of discharge for cause that is accepted by the Company in lieu of a formal discharge for cause shall be deemed a termination of employment for cause for purposes
hereof. 
  

 1 








 (c) If the Optionee dies while employed by the Company or within ninety (90) days after the Optionee
ceases active employment due to disability, each option held by the Optionee immediately prior to death may be exercised, to the extent it was exercisable immediately prior to death, by the Optionee’s executor or administrator or by the person
or persons to whom the option is transferred by will or the applicable laws of descent and distribution, at any time within a one-year period beginning with the date of the Optionee’s death, but in no event beyond the Expiration Date.

 (d) If the Optionee’s employment with the Company terminates for any reason other then cause or death, all options held by the
Optionee that are not then exercisable, shall terminate. Options that are exercisable as of the date employment terminates shall be exercisable by the Optionee during the ninety (90) days following such termination, but only as to the number of
shares, if any, as to which the Option was exercisable immediately prior to such termination and in no event after the Expiration Date. 
 (e)
In the event exercise of the Option shall require the Company to issue a fractional share of Common Stock of the Company, such fraction shall be disregarded and the purchase price payable in connection with such exercise shall be appropriately
reduced. Any such fractional share shall be carried forward and added to any shares covered by future exercise(s) of the Option. 
 3. The
Option shall not be transferable other than by will or by the laws of descent and distribution and shall be exercisable during the Optionee’s lifetime only by the Optionee. 
 4. This Option shall not be treated as an incentive stock option. 
 5. Any brokerage fees or commissions, and all taxes are the responsibility of the Optionee. 
 WITNESS the execution hereof
as of May 12th of 2006. 
  

			
	Nabi Biopharmaceuticals
		
	By	 	 /s/ Thomas H. McLain

		 	Thomas H. McLain, Chairman
		 	Chief Executive Officer & President


 By signing this Letter Agreement below, the Optionee hereby acknowledges and agrees that
he/she has read, understands and accepts all of the terms and conditions set forth herein and set forth in the Nabi 2000 Equity Incentive Plan. 
  

	
	 /s/ Adam Logal

	Optionee Signature
	
	 Adam Logal

	Print Name


 2000 Equity Incentive Plan 
  

 2